# Topical Tranexamic Acid (TXA) in Joint Arthroplasty

> **NCT01937559** · PHASE4 · COMPLETED · sponsor: **The Hawkins Foundation** · enrollment: 188 (actual)

## Conditions studied

- Osteoarthritis
- Hip Arthropathy
- Shoulder Arthropathy

## Interventions

- **BIOLOGICAL:** Tranexamic acid (TXA)
- **DRUG:** Normal saline

## Key facts

- **NCT ID:** NCT01937559
- **Lead sponsor:** The Hawkins Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-04
- **Primary completion:** 2018-06
- **Final completion:** 2018-11
- **Target enrollment:** 188 (ACTUAL)
- **Last updated:** 2020-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01937559

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01937559, "Topical Tranexamic Acid (TXA) in Joint Arthroplasty". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01937559. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*